Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...

The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...

Researchers are developing genomic screening tools to tailor radiation dose and hormone therapy for prostate cancer patients, ...

Women’s HRT patches control prostate cancer as well as standard hormone injections, but with fewer hot flushes and less bone ...

For men who have a detectable PSA of 0.5 ng/mL or less after radical prostatectomy and before salvage radiation therapy, hormone therapy may provide no overall survival or metastasis-free survival ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

A recent abstract published in Nature Communications outlines a new, easy-to-use tool that could help guide early treatment discussions for people with mHSPC. In a nutshell, the innovative system ...

Focal therapy now helping in the fight against prostate cancer With focal therapy, doctors are now able to destroy cancer cells without damaging the surrounding nerves and tissue. In today’s ...

CINCINNATI (WKRC) - Doctors at the Urology Group are pioneering the use of artificial intelligence to enhance prostate cancer treatment, offering patients like Terry Hawk a new level of targeted ...

Digital Health News: Daniel Spratt, chair of radiation oncology at Case Comprehensive Cancer Center, commented on a new AI-enabled prostate cancer risk assessment tool has been developed to analyze ...